Chlorhexidine for facility-based umbilical cord care:
| dc.contributor.author | Zaman, S, B | |
| dc.contributor.author | Siddique, A ,B | |
| dc.contributor.author | Ruysen, H | |
| dc.contributor.author | KC, A | |
| dc.contributor.author | Peven, K | |
| dc.contributor.author | Ameen, S | |
| dc.contributor.author | Thakur, N | |
| dc.contributor.author | Rahman, Q, S | |
| dc.contributor.author | Salim, N | |
| dc.contributor.author | Gurung, R | |
| dc.contributor.author | Tahsina, T | |
| dc.contributor.author | Rahman, A, E | |
| dc.contributor.author | Coffey, P, S | |
| dc.contributor.author | Rawlins, B | |
| dc.contributor.author | Day, L, T. | |
| dc.contributor.author | Lawn, J, E. | |
| dc.contributor.author | Arifeen, S, E | |
| dc.contributor.author | El Arifeen, S | |
| dc.contributor.author | EN-BIRTH Study Group | |
| dc.date.accessioned | 2023-04-28T19:58:00Z | |
| dc.date.available | 2023-04-28T19:58:00Z | |
| dc.date.issued | 2021 | |
| dc.description.abstract | Background: Umbilical cord hygiene prevents sepsis, a leading cause of neonatal mortality. The World Health Organization recommends 7.1% chlorhexidine digluconate (CHX) application to the umbilicus after home birth in high mortality contexts. In Bangladesh and Nepal, national policies recommend CHX use for all facility births. Population-based household surveys include optional questions on CHX use, but indicator validation studies are lacking. The Every Newborn Birth Indicators Research Tracking in Hospitals (EN-BIRTH) was an observational study assessing measurement validity for maternal and newborn indicators. This paper reports results regarding CHX. Methods: The EN-BIRTH study (July 2017–July 2018) included three public hospitals in Bangladesh and Nepal where CHX cord application is routine. Clinical-observers collected tablet-based, time-stamped data regarding cord care during admission to labour and delivery wards as the gold standard to assess accuracy of women’s report at exit survey, and of routine-register data. We calculated validity ratios and individual-level validation metrics; analysed coverage, quality and measurement gaps. We conducted qualitative interviews to assess barriers and enablers to routine register-recording. Results: Umbilical cord care was observed for 12,379 live births. Observer-assessed CHX coverage was very high at 89.3–99.4% in all 3 hospitals, although slightly lower after caesarean births in Azimpur (86.8%), Bangladesh. Exit survey-reported coverage (0.4–45.9%) underestimated the observed coverage with substantial “don’t know” responses (55.5–79.4%). Survey-reported validity ratios were all poor (0.01 to 0.38). Register-recorded coverage in the specific column in Bangladesh was underestimated by 0.2% in Kushtia but overestimated by 9.0% in Azimpur. Register-recorded validity ratios were good (0.9 to 1.1) in Bangladesh, and poor (0.8) in Nepal. The non-specific register column in Pokhara, Nepal substantially underestimated coverage (20.7%). Conclusions: Exit survey-report highly underestimated observed CHX coverage in all three hospitals. Routine register-recorded coverage was closer to observer-assessed coverage than survey reports in all hospitals, including for caesarean births, and was more accurately captured in hospitals with a specific register column. Inclusion of CHX cord care into registers, and tallied into health management information system platforms, is justified in countries with national policies for facility-based use, but requires implementation research to assess register design and data flow within health information systems | en_US |
| dc.identifier.uri | http://dspace.muhas.ac.tz:8080/xmlui/handle/123456789/3322 | |
| dc.language.iso | en | en_US |
| dc.publisher | BMC Pregnancy and Childbirth | en_US |
| dc.relation.ispartofseries | Vol 21;No 239 | |
| dc.subject | Birth | en_US |
| dc.subject | Newborn | en_US |
| dc.subject | Coverage | en_US |
| dc.subject | Validity | en_US |
| dc.subject | Survey | en_US |
| dc.subject | Hospital records | en_US |
| dc.subject | Health management systems | en_US |
| dc.subject | 7.1% chlorhexidine | en_US |
| dc.subject | Umbilical cord care | en_US |
| dc.subject | Neonatal sepsis | en_US |
| dc.title | Chlorhexidine for facility-based umbilical cord care: | en_US |
| dc.title.alternative | EN-BIRTH multi-country validation study | en_US |
| dc.type | Article | en_US |
